20 February 2025
Nucala (mepolizumab) application for COPD accepted for review in China GSK plc (LSE/NYSE: GSK) today announced that the China National Medical Products Administration has accepted for review the new…
RESULTS FOR THE FULL YEAR “In 2024 we continued to Help Britain Prosper, delivering for our customers, shareholders and wider stakeholders. We successfully completed…
19 February 2025
Jet2 plc (“the Group” or “the Company”) Trading Update Year ending 31 March 2025 (FY25) Winter 2024/25 on sale capacity at 5.1m seats is…
Statement re Possible Offer from Kohlberg Kravis Roberts & Co. Partners L.L.P. (“KKR”) The Board of Assura plc (“Assura” or the “Company”) notes the…
18 February 2025
BHP Group Limited Financial results for the half year ended 31 December 2024 18 February 2025 Operational excellence underpins strong returns and investment in…
Euronext publishes Q4 and full year 2024 results Euronext delivered double-digit revenue growth in 2024 thanks to its diversified revenue profile and confirms the…
17 February 2025
Penmenvy, GSK’s 5-in-1 meningococcal vaccine, approved by US FDA to help protect against MenABCWY GSK plc (LSE/NYSE: GSK) today announced that the US Food and…
13 February 2025
The Scottish American Investment Company P.L.C. Legal Entity Identifier: 549300NF03XVC5IFB447 Regulated Information Classification: Additional regulated information required to be disclosed under the applicable laws…